Professor, Department of Psychiatry and Behavioral Sciences
Professor, Department of Family Medicine
Professor, Department of Pediatrics
Associate Dean for Continuing Medical Education, College of Medicine
Director, University Offices of Research Integrity: IRB/IACUC/IBC |
EDUCATION
| University of Maryland, College Park, MD | B.S. | 1965 | Psychology | | Medical University of South Carolina, Charleston, SC | M.D. | 1970 | Medicine | | Stanford University Medical Center, Stanford, CA | Residency | 1974 | Psychiatry | | Medical University of South Carolina, Charleston, SC | Postdoctoral | 1978 | Family Practice |
PROFESSIONAL EXPERIENCE | 1974-1979 | Research Director, Weight Management Clinic, MUSC, Charleston, SC | | 1975-1979 | Assistant Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1979-1990 | Associate Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1984-1987 | Medical Director, Alcohol and Drug Treatment Unit, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC | | 1990-present | Professor, Departments of Psychiatry & Behavioral Sciences, Family Medicine, and Pediatrics, MUSC, Charleston, SC | | 1991-2001 | Medical Director, Center for Drug and Alcohol Programs, MUSC, Charleston, SC | | 2001-present | Associate Dean for Continuing Medical Education, MUSC, Charleston, SC
| | 2003-2006 | Chairman, Institutional Review Board for Commercial Grants, MUSC, Charleston, SC | | 2006-2007 | Chair (Interim), Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 2007-2009 | Director, University Offices of Research Integrity: IRB/IACUC/IBC, MUSC, Charleston, SC |
AWARDS AND HONORS | 1967-1970 | NIH Fellowship | | 1971-1973 | NIMH Fellowship | | 1985-1986 | Excellence in Teaching Award, Medical University of South Carolina | | 1987 | Golden Apple Teaching Award, Medical University of South Carolina | | 1988 | Elected Fellow, American Psychiatric Association | | 1994-1996 | Member, Special Review, NIDA Clinical Research | | 1996-2002 | Member, Treatment Research Subcommittee, NIDA-E | | 2001-2002 | Chairman, Treatment Research Subcommittee, NIDA-E | | 2003-2005 | Treasurer, NIDA Review Committees | | 2003-2009 | Member, NIDA Centers Review Committee | | 2006-2010 | Member, NIDA Data and Safety Monitoring Board for Medication Development | | 2007-2008 | Chairman, Statewide Medicaid Academic Detailing Project |
PUBLICATIONS (2006-present)
Ait-Daoud N, Malcolm RJ, Jr. & Johnson BA. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addictive Behaviors 31(9):1628-1649, 2006. Center for Substance Abuse Treatment (Consensus Panel Member, Malcolm RJ). Detoxification and Substance Abuse Treatment. In Treatment Improvement Protocol (TIP) Series 45, Vol DHHS Publication No. (SMA) 06-4131. Substance Abuse and Mental Health Services Administration, Rockville, MD, 2006. Hedden SL, Woolson RF & Malcolm RJ. Randomization in substance abuse clinical trials. Substance Abuse Treatment, Prevention, and Policy 1(1):6, 2006. LaRowe SD, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, Saladin M, McRae A & Brady K. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. American Journal on Addictions 15(1):105-110, 2006. Malcolm R, Swayngim K, Donovan JL, DeVane CL, Elkashef A, Chiang N, Khan R, Mojsiak J, Myrick DL, Hedden S, Cochran K & Woolson RF. Modafinil and cocaine interactions. American Journal of Drug & Alcohol Abuse 32(4):577-587, 2006. Markowitz JS, DeVane CL, Malcolm RJ, Gefroh HA, Wang JS, Zhu HJ & Donovan JL. Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers. Journal of Clinical Pharmacology 46(2):164-171, 2006. Wright T, Myrick H, Henderson S, Peters H & Malcolm R. Risk factors for delirium tremens: A retrospective chart review. American Journal on Addictions 15(3):213-219, 2006. Gerrard P & Malcolm R. Mechanisms of modafinil: A review of current research. Neuropsychiatric Disease and Treatment 3(3):349-364, 2007. Larowe SD, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A, Brady K, Kalivas PW & Malcolm R. Is cocaine desire reduced by N-acetylcysteine? American Journal of Psychiatry 164(7):1115-1117, 2007. Mabry PL, Tooze JA, Moser RP, Augustson EM, Malcolm RJ & Benowitz NL. Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: Results from a pilot study with African American men. Nicotine & Tobacco Research 9(1):65-82, 2007. Malcolm R, Myrick H, Veatch LM, Boyle E & Randall PK. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: A randomized, double-blind, controlled comparison of lorazepam vs gabapentin. Journal of Clinical Sleep Medicine 3(1):24-32, 2007. Mardikian PN, Larowe SD, Hedden S, Kalivas PW & Malcolm RJ. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31(2):389-394, 2007. McRae AL, Hedden SL, Malcolm RJ, Carter RE & Brady KT. Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials. Addictive Behaviors 32:1433-1440, 2007. Nguyen SA, Malcolm R & Middaugh LD. Topiramate reduces ethanol consumption by C57BL/6 mice. Synapse 61(3):150-156, 2007. Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, Malcolm R, Janis GC & Markowitz JS. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clinical Pharmacology & Therapeutics 81(3):346-353, 2007. Wright TM, Myrick H, Malcolm R, Randall P, Boyle E, Henderson S & Anton R. Impact of lifetime alcohol quit attempts and medicated detoxifications on time to relapse during an index alcohol detoxification. Journal of Addiction Medicine 1(1):15-20, 2007. |
